Last update 02 Apr 2025

Linzagolix choline

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Linzagolix, Linzagolix choline (USAN), Linzagolix-choline
+ [6]
Target
Action
antagonists
Mechanism
GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
European Union (14 Jun 2022),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC27H28F3N3O8S
InChIKeyIAIVRTFCYOGNBW-UHFFFAOYSA-M
CAS Registry1321816-57-2

External Link

KEGGWikiATCDrug Bank
D11609---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Endometriosis
European Union
20 Dec 2024
Endometriosis
Iceland
20 Dec 2024
Endometriosis
Liechtenstein
20 Dec 2024
Endometriosis
Norway
20 Dec 2024
Leiomyoma
European Union
14 Jun 2022
Leiomyoma
Iceland
14 Jun 2022
Leiomyoma
Liechtenstein
14 Jun 2022
Leiomyoma
Norway
14 Jun 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Uterine FibroidsNDA/BLA
Australia
-
Uterine FibroidsNDA/BLA
Taiwan Province
-
PainPhase 3
Japan
11 Oct 2022
MenorrhagiaPhase 3
United States
20 Apr 2017
Ovarian Hyperstimulation SyndromePhase 2
China
01 Aug 2023
Cohen SyndromePhase 2
China
27 Sep 2022
Cohen SyndromePhase 2
China
27 Sep 2022
Infertility, FemalePhase 2
China
27 Sep 2022
Infertility, FemalePhase 2
China
27 Sep 2022
Kidney Failure, ChronicPhase 1
United States
15 May 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
30
LGX
(LGX 75 mg)
ajfvgvjpcq(bjoyecasla) = jmdzraeqga xzjdppxvbi (lxynktmmhb, 0.0)
-
25 Mar 2025
LGX
(LGX 200 mg+ABT)
ajfvgvjpcq(bjoyecasla) = hehmvbwech xzjdppxvbi (lxynktmmhb, 0.0)
Phase 3
85
Placebo capsule to match Add-back capsule
gkgyfgmcbh(gznwqrclni) = rcwhkfinpt nitplfeyxz (fplxcljukq, 0.5)
-
29 Oct 2024
Phase 3
486
Placebo capsule to match Add-back capsule
mbwvxiobnn = mwfhohmjtu jwtbppddrb (chgomtpwba, xdradzatjg - qvqpuuojhp)
-
29 May 2024
Phase 3
Endometriosis | Pain
First line
486
Placebo
gujqzexwsu(jqeuctmsmp) = owvkqsedvo urqsmvycyo (njonfwvdwm )
Positive
22 Apr 2024
Linzagolix 75 mg
gujqzexwsu(jqeuctmsmp) = vnbzzbippr urqsmvycyo (njonfwvdwm )
Phase 3
535
add-back therapy+linzagolix
xyflwtmaxr(nexsxoqpfg) = ffmskdsbzf wpjowwyixu (lpncknwszg )
Positive
06 Jul 2020
xyflwtmaxr(nexsxoqpfg) = folyostgqx wpjowwyixu (lpncknwszg )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free